Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC Has Been Notified Regarding Fictitious Dividend Announcement

Where do we send our complaints regarding Alliacense's strongly exaggerated PR language used over the last several years? Language that both parties knew would potentially rally investors. Language, that I might add, PTSC never disputed. Amazing how one partner stayed conservative in their PR's, while the other ran rampant. We know, PTSC has to adhere to SEC regulations while TPL is private. I believe that is called a relationship of convenience.

Share
New Message
Please login to post a reply